期刊文献+

转基因马铃薯中人白介素-12体外诱导人肝癌细胞凋亡的研究 被引量:3

The in vitro Anti Hptocarcinoma Effects of Human Interleukin-12 from Transgenic Potato
下载PDF
导出
摘要 [目的]检测从人白介素-12(human interleukin12,hIL-12)转基因马铃薯中提取的hIL-12的抗肝癌效应。[方法]用MTT法检测转基因马铃薯中hIL-12对人肝癌细胞HepG22.2.15的体外杀伤作用;用AnnexinV/PI双染色法加激光共聚焦显微镜观察转基因马铃薯中hIL-12对HepG22.2.15细胞的诱导凋亡作用。[结果]转基因马铃薯中表达的hIL-12与重组人白介素-12(rhIL-12)在体外对HepG22.2.15具有杀伤作用,而野生对照组无杀伤作用;AnnexinV/PI双染色法加激光共聚焦显微镜观察结果表明,转基因马铃薯中表达hIL-12可诱导HepG22.2.15细胞凋亡。[结论]转基因马铃薯表达体系表达的人白介素-12具有抗肝癌细胞增殖、促进肝癌细胞凋亡的作用。 [Objective] The aim was to examine the anti-heptocarcinoma effects of human interleukin-12(hIL-12)from transgenic potatoes.[Method] Human heptocarcinoma cell line HepG22.2.15 was cocultured with human peripherial blood monocyte(PBMC).Human IL-12 extracted from its transgenic patatoes was introduced to this coculture system.MTT method and laser confocal microscope were then employed to evaluate its survival rates and morphological changes of HepG22.2.15 cell line.[Result] The HepG22.2.15 survival rate of the plant produced hIL-12 treated group was significantly lower than that of the wild type control,while similar to that of commercial purified recombinant hIL-12 group.As indicated by AnnexinV/PI double staining laser confocal microscope,cocultured heptocarcinoma cells showed the typical early and final phase apoptotic morphological characteristics 48 hours after 2×10-4 mg/L potato secreted hIL-12 treatment.[Conclusion] These results demonstrated that Heptocarcinoma HepG22.2.15 cell grouth could be actively inhibited by the transgenic potato expressed hIL-12 in vitro.
出处 《安徽农业科学》 CAS 北大核心 2010年第21期11069-11070,11074,共3页 Journal of Anhui Agricultural Sciences
基金 贵州省教育厅重点项目"人白介素-12植物表达体系的建立"(2004118)
关键词 人白介素-12 抗肿瘤作用 转基因马铃薯 Hman interleukin-12 Anti-tumor effects Transgenic potato
  • 相关文献

参考文献14

  • 1HAMZA T,BARNETT J B,LI B.Interleukin 12 a Key Immunoregulatory Cytokine in Infection Applications[J].International Journal of Molecular Sciences,2010,11(3):789-806.
  • 2SUDA T,KAMIMURA K,KUBOTA T,et al.Progress toward liver-based gene therapy[J].Hepatology research,2009,39(4):325-340.
  • 3DEL VECCHIO M,BAJETTA E,CANOVA S,et al.Interleukin-12:biological properties and clinical application[J].Clinical Cancer Research:an Official Journal of the American Association for Cancer Research,2007,13(16):4677.
  • 4CHANG C J,CJEN Y H,HUANG K W,et al.Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors[J].Hepatology(Baltimore,Md),2007,45(3):746.
  • 5PERON J,COUDERC B,ROCHAIX P,et al.Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12[J].Journal of Gastroenterology and Hepatology,2004,19(4):388-396.
  • 6SHIN Y J,LEE N J,KIM J,et al.High-level production of bioactive heterodimeric protein human interleukin-12 in rice[J].Enzyme and Microbial Technology,2010,46(5):347-351.
  • 7邵敏,周鹤峰,葛正龙.人白介素-12植物表达载体的构建[J].第四军医大学学报,2007,28(10):868-870. 被引量:14
  • 8陈佳瑜,罗果,葛正龙.人白介素-12转基因马铃薯中hIL-12的表达[J].安徽农业科学,2010,38(15):7767-7768. 被引量:7
  • 9UEMURA A,TAKEHARA T,MIYAGI T,et al.Natural killer cell is a major producer of interferon gamma that is critical for the IL-12-induced anti-tumor effect in mice[J].Cancer Immunol Immunother,2010,59(3):453-463.
  • 10ANWER K,BARNES M N,FEWELL J,et al.Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer[J].Gene Ther,2010,17(3):360-369.

二级参考文献44

共引文献31

同被引文献37

  • 1杨娜,朱开梅,顾生玖.从槐米中提取槲皮素方法的研究进展[J].时珍国医国药,2010,21(12):3340-3341. 被引量:15
  • 2张杰,吕蔡,张平安,詹炳炎,余小祥.槲皮素抑制人宫颈癌HeLa细胞增殖的实验研究[J].中国肿瘤临床,2006,33(8):436-438. 被引量:18
  • 3高静,栾信庸,许风雷,雷大鹏,刘大昱.槲皮素对喉癌细胞Hep-2的抑制增殖和诱导凋亡作用[J].南京中医药大学学报,2006,22(3):177-178. 被引量:8
  • 4李翠云,段小娴.肝癌动物模型研究进展[J].医学研究杂志,2006,35(10):71-73. 被引量:6
  • 5AMERICAN CANCER SOCIETY. Global Cancer Facts & Figures 2007 [ EB/OL]. http ://www cancer org/doeroot/S'lT/stt_0 2007 asp? sitearea = STF&level = 1.
  • 6FARAZI P A, DEPINHO R A. IAepatocel lular carcinoma pathogenesis: from genes to environment [ J ]. Nat Rev Cancer,2006,6:674 - 687.
  • 7LLOVET J M, BURROUGHS A, BRUIX J. Hepatocellular carcinoma [ J ]. lancet ,2003,362 : 1907 - 1917.
  • 8FRESE K K, TUVESON D A. Maximizing mouse cancer models [ J ]. Nat Rev Cancer 2007,7:645 - 658.
  • 9NAUGLER W E,SAKURAI T, KIM S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production [ J ]. Science,2007,317 : 121 - 124.
  • 10CHEN C J,YU M W,LIAW Y F. Epidemiological characteristics and risk factors of hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol, 1997,12 : 294-308.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部